Activity
-
Mayence Dom
-
North Carolina Biotech Center
-
API 1.2
- Interface specifications for OpenTox services (Version 1.2).
-
Validation statistics
-
Validation
-
Validation FAQ
- Frequently asked questions about the validation
-
Collaborative Protege
-
open project
-
API
-
Test Web Services
- Descriptions and links to OpenTox web services
-
Final Validation Routines with Facilities to Validate Against Confidential Data
- OpenTox D5.4 Report on Final Validation Routines with Facilities to Validate Against Confidential Data
-
Final Version of (Q)SAR algorithms
- OpenTox D4.3 Report on Final Version of (Q)SAR algorithms
-
Final Database with Additional Content
- OpenTox D3.4 Report on Final Database with Additional Content
-
Final Framework
- OpenTox D2.4 Report on Final Framework
-
Evaluation of the Final Implementation
- OpenTox D1.4 Report on Evaluation of the Final Implementation
-
Collaborative Virtual Organisation and Infrastructure for Anti-Malarial Drug Design
- Presentation by Barry Hardy at the BIO-IT Europe 2011 conference in Hannover, 12 October 2011, in the Collaborative Drug Design program. OpenTox is contributing to the Scientists Against Malaria initiative through the holistic incorporation of predictive toxicology modelling of drug design libraries using weight of evidence–based workflows across public and commercial resources.
-
Presentations
- folder for presentation materials
-
Effects Respiratory Tract (owl)
-
Organ Endpoints Ontology (owl)
-
Toxicological Endpoints Ontology (owl)

